Wisevoter
U.S.

Skyrizi Led National TV Pharma Advertising in August

The drug manufacturer dominated national TV airwaves with 2.8 billion impressions during the month of August 2026.

Updated on Sept. 29, 2026 in Advertising

Isometric editorial illustration of a matte pill bottle atop geometric broadcast frequency waves in muted business tones.
Skyrizi captured the largest share of national television pharmaceutical advertising in August 2026, reaching 2.8 billion total impressions. AI Illustration. Upload story photo >

Live Poll

Does seeing constant TV ads for prescription drugs make you trust those medications more?

Skyrizi secured the top spot in national television pharmaceutical advertising during August 2026, generating 2.8 billion total impressions. The brand maintained a 4.9% share of voice in the highly competitive national television pharma market.

Why it matters

Pharmaceutical companies are increasingly targeting specific broadcast programming to maximize reach, with WNBA events seeing a 289% year-over-year increase in pharma impressions. Strategic media placement across major networks remains a primary driver for drug visibility in the United States.

Skyrizi commanded a 4.9% share of voice in national TV pharma advertising with 2.8 billion impressions. The brand utilized a total spend of $30.4 million, slightly lower than the $31.2 million spent by Bimzelx, which reached 1.7 billion impressions.

The players

Skyrizi

This is a pharmaceutical medication used for the treatment of plaque psoriasis and psoriatic arthritis.

Colgate

This is a global consumer products company that manufactures oral hygiene products including toothpaste and toothbrushes.

ABC

This is an American commercial broadcast television network that serves as a major platform for national advertising campaigns.

The details

While Skyrizi topped TV charts, Colgate emerged as the health brand leader on YouTube with 160 million views, supported by the upload of 18 YouTube Shorts. Meanwhile, Bimzelx leveraged NFL preseason programming to reach audiences, while ABC captured 10.95% of total broadcast pharma impressions.

Timeline

  1. August 2025 marked the baseline for WNBA pharma impression growth.

  2. July 2026 saw Claritin generate 151 million YouTube views.

  3. August 2026 served as the primary observation month for television and YouTube rankings.

Market Landscape

The advertising sector is currently defined by a heavy migration of pharma spending into high-engagement live sports programming, such as the 289% year-over-year increase in WNBA impressions. This shift forces legacy broadcast networks to compete more aggressively for pharmaceutical ad budgets against digital-first strategies.

Consumers are likely to encounter these pharmaceutical advertisements more frequently during live sports broadcasts and on digital platforms like YouTube. This saturation reflects how brands prioritize high-visibility programming to influence patient conversations with healthcare providers.

The takeaway

The move toward short-form video and high-visibility live sports content indicates a major shift in how health brands attempt to cut through media clutter. Viewers should expect continued high-frequency advertising during major athletic events as companies vie for limited consumer attention.

Further reading

For more information on current industry trends, visit the Advertising section.

Source note: This article includes information reported by MM+M - Medical Marketing and Media.

Live Poll

Does seeing constant TV ads for prescription drugs make you trust those medications more?